netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.02.03  Expand sub section  Drugs used for mania and hypomania
04.02.03  Expand sub section  Valproic acid
Valproic Acid (Semisodium)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Valproic Acid Tablet EC 250mg (As Semisodium Valproate)
Valproic Acid Tablet EC 500mg (As Semisodium Valproate)

Please see the following links to materials to support the new Valproate Pregnancy Prevention Programme:

Patient Card – to be given by pharmacists to all female patients who are dispensed valproate medicines to inform them of the risks
Patient Guide – to be provided to girls (of any age) and women of childbearing potential (or their parent/caregiver/responsible person) taking any medicine containing valproate
Guide for healthcare professionals – for all prescribers, pharmacists, and other healthcare providers involved in the care of women and girls of childbearing potential using valproate medicines
Risk Acknowledgement Form – for the specialist and patient (or their parent/caregiver/responsible person) to sign at initiation and at treatment reviews at least every year. The patient should receive a copy of the form; one copy should be filed in the specialist notes, and one copy sent to the patient’s GP

 
   
04.02.03  Expand sub section  Lithium
Lithium Carbonate
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E

Prescribe by Brand and maintain patient on the same Brand

Current Brands Available:
Camcolit, Lithonate, Liskonum and Priadel Tablets


Note change in bioavailability when changing from Tablets to Liquid. Lithium citrate tetrahydrate 520 mg (liquid) is equivalent to lithium carbonate 204 mg (tablet)

Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment (Litium Carbonate)

See link below for ESCA. Please use the ESCA under the title Agreements - South Staffordshire CCG Locality

 
Link  Essential Shared Care Agreements (ESCA’s) - MPFT
   
Lithium Citrate
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E

Prescribe by Brand and maintain patient on the same Brand

Current Brands Available:
Priadel Liquid and Li-liquid

Note change in bioavailability when changing from Tablets to Liquid. Note Lithium citrate tetrahydrate 520 mg is equivalent to lithium carbonate 204 mg.
Preparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment (Lithium Carbonate)

See link below for ESCA. Please use the ESCA under the title Agreements - South Staffordshire CCG Locality

 
Link  Essential Shared Care Agreements (ESCA’s) - MPFT
Link  Safer Lithium Therapy
   
 ....
 Non Formulary Items
Asenapine

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs which require special consideration. These are drugs for Consultant Prescribing ONLY. They should not be prescribed in Primary Care.  

Amber

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care. For some drugs there may be a Ricad in place to aid the transition to primary care.  

Amber E

Drugs that should be initiated by a Specialist but are suitable for continuation in Primary Care but also require and ESCA (Shared Care Agreement)   

Green

Suitable first-line drugs for implementation in Primary Care  

On Formulary

South Staffs Formulary Choice  

netFormulary